The ANP32E Knockout HeLa Polyclonal Cells comprise a heterogeneous population of HeLa cells in which the ANP32E gene has been disrupted by CRISPR/Cas9-mediated gene editing. This polyclonal knockout model provides a robust loss-of-function tool for investigating the cellular roles of ANP32E without the clonal bias inherent in single-cell-derived lines. The product is supplied as a mixed population of edited cells, enabling researchers to study the average effects of ANP32E deficiency in a genetically diverse yet homogeneous cellular background. The knockout strategy employs CRISPR/Cas9 to introduce targeted disruptions in the ANP32E locus, generating a stable knockout model that faithfully represents the multifaceted nature of gene inactivation in a polyclonal setting.
The host cell line is HeLa, a widely used immortalized cell line derived from a human cervical adenocarcinoma. HeLa cells exhibit an epithelial morphology and retain key characteristics of cervical carcinoma, including rapid proliferation, altered cell cycle control, and resistance to apoptosis. These features make HeLa cells a well-established model for studying cancer biology, particularly tumor progression and molecular mechanisms of oncogenesis. The robust growth and ease of genetic manipulation allow for reproducible knockout generation and functional studies in a relevant cervical cancer context.
ANP32E, also known as LANP-like protein or acidic leucine-rich nuclear phosphoprotein 32 family member E, is a histone chaperone that functions as a potent inhibitor of histone acetylation. It acts by directly binding to histones and forming inhibitory complexes with histone acetyltransferases such as p300/CBP, thereby repressing transcription. ANP32E is a core component of the INHAT (inhibitor of acetyltransferases) complex, which also includes SET/TAF-I??. This scaffold interacts with importin for nuclear transport and is regulated by upstream factors including E2F1, MYC, and p53, placing it at the crossroads of cell cycle control and apoptosis. Downstream, ANP32E modulates the activity of p300/CBP and the expression of cell cycle regulators, linking chromatin dynamics to proliferative signaling.
In the HeLa cervical carcinoma background, ANP32E knockout provides a physiologically relevant model to dissect its contributions to tumor cell biology. Elevated histone acetylation following ANP32E loss leads to chromatin decondensation and aberrant transcriptional activation, potentially driving cell cycle dysregulation and altered apoptotic sensitivity. This model is particularly valuable for exploring how histone chaperone dysfunction influences oncogenic processes, as ANP32E is implicated in cervical cancer progression. By studying polyclonal knockout cells, researchers can assess global chromatin changes without clonal artifacts, paralleling the heterogeneity seen in tumors.
Typical research applications include chromatin biology and transcriptional regulation studies, where researchers can perform western blotting for site-specific histone acetylation marks (e.g., H3K9ac, H3K27ac) to quantify global acetylation changes. Chromatin immunoprecipitation coupled with quantitative PCR (ChIP-qPCR) enables mapping of altered histone modifications at target gene promoters, while RT-qPCR assesses downstream gene expression shifts. Immunofluorescence can visualize changes in nuclear histone acetylation patterns, and flow cytometry permits cell cycle profiling to link ANP32E loss to proliferative defects. Apoptosis assays further clarify its role in cell death pathways. For technical inquiries or to integrate this model into your research, please contact Ascent Research.
